PortfoliosLab logoPortfoliosLab logo
ISIN
US09090D1037
CUSIP
09090D103
IPO Date
Mar 13, 2019

Highlights

Market Cap
$2.26B
Enterprise Value
$2.26B
EPS (TTM)
-$0.01
Gross Profit (TTM)
-$2.69M
EBITDA (TTM)
-$25.59M
Year Range
$0.36 - $14.71
Target Price
$38.00
ROA (TTM)
-289.14%
ROE (TTM)
1,066.97%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BiomX Inc.

Performance

PHGE Performance Chart

BiomX Inc. (PHGE) is down 53.6% since the beginning of the year. At $1 per share, PHGE is trading 94.1% below its 52-week high of $15. Investors who bought $1,000 worth of PHGE shares 5 years ago would now be looking at an investment worth $1.


Loading charts...

S&P 500 Index

Returns By Period

BiomX Inc. (PHGE) has returned -53.57% so far this year and -90.88% over the past 12 months.


BiomX Inc.

1D
-0.82%
1M
15.76%
YTD
-53.57%
6M
-80.75%
1Y
-90.88%
3Y*
-77.02%
5Y*
-76.28%
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PHGE Monthly Returns History

Based on dividend-adjusted daily data since Mar 13, 2019, PHGE's average daily return is -0.12%, while the average monthly return is -3.51%.

Historically, 34% of months were positive and 66% were negative. The best month was Jan 2026 with a return of +205.9%, while the worst month was Apr 2026 at -77.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 12 months.

On a daily basis, PHGE closed higher 40% of trading days. The best single day was Mar 6, 2024 with a return of +197.7%, while the worst single day was Nov 29, 2023 at -46.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026205.88%-23.60%-14.10%-77.36%48.24%-31.10%-53.57%
2025-0.16%-14.35%-10.99%9.59%-19.54%-8.16%-13.44%38.56%-2.72%-5.90%-53.55%-57.11%-86.52%
2024-14.36%-12.43%114.29%6.44%-16.49%-15.98%-34.54%-44.55%-16.39%-24.51%-7.79%2.83%-73.93%
202399.52%7.71%-23.98%-11.48%33.33%0.00%19.44%-6.98%-12.00%-17.41%-10.90%8.11%49.97%
2022-5.00%-3.29%31.29%-24.35%-54.10%8.94%22.90%-38.70%-38.18%5.88%-20.58%-34.70%-88.33%
20213.06%10.57%-2.06%-2.67%-12.99%-9.45%-16.66%-12.76%-22.92%-27.45%-15.32%-14.89%-74.92%

Benchmark Metrics

BiomX Inc. has an annualized alpha of -30.72%, beta of 0.49, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 14, 2019.

  • This stock participated in 219.10% of S&P 500 Index downside but only -75.75% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.49 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-30.72%
Beta
0.49
0.00
Upside Capture
-75.75%
Downside Capture
219.10%

Return for Risk

Risk / Return Rank

PHGE ranks 14 for risk / return — in the bottom 14% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


PHGE Risk / Return Rank: 1414
Overall Rank
PHGE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
PHGE Sortino Ratio Rank: 2020
Sortino Ratio Rank
PHGE Omega Ratio Rank: 2121
Omega Ratio Rank
PHGE Calmar Ratio Rank: 55
Calmar Ratio Rank
PHGE Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for BiomX Inc. (PHGE) and compare them to S&P 500 Index.


PHGEBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.68

Sortino ratioReturn per unit of downside risk

-3.58

Omega ratioGain probability vs. loss probability

0.94

1.41

-0.46

Calmar ratioReturn relative to maximum drawdown

-0.94

2.93

-3.87

Martin ratioReturn relative to average drawdown

-1.61

13.52

-15.13

Dividends

Dividend History


BiomX Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the BiomX Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BiomX Inc. was 99.98%, occurring on May 19, 2026. The portfolio has not yet recovered.

The current BiomX Inc. drawdown is 99.96%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-99.98%May 2026
6y 6mo
6y 7moOct 2019 - now
2019 pullback2019
-7.24%Oct 2019
3mo4d
3mo 4dJul 2019 - Oct 2019
2019 pullback2019
-3.10%May 2019
1mo 10d2mo 17d
3mo 27dMar 2019 - Jul 2019
2019 pullback2019
-1.50%Jul 2019
0s1d
1dJul 2019 - Jul 2019

Drawdown Indicators


PHGEBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-56.78%

-43.20%

Max Drawdown (1Y)

Largest decline over 1 year

-96.97%

-9.10%

-87.87%

Max Drawdown (3Y)

Largest decline over 3 years

-99.71%

-18.90%

-80.81%

Max Drawdown (5Y)

Largest decline over 5 years

-99.97%

-25.43%

-74.54%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-99.96%

-0.74%

-99.22%

Average Drawdown

Average peak-to-trough decline

-72.80%

-10.72%

-62.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

56.45%

1.97%

+54.48%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BiomX Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how BiomX Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with PHGE

Add BiomX Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with PHGE